Retatrutide Research Review: A Triple GLP-1/GIP/Glucagon Receptor Agonist for Metabolic Studies
A research-focused overview of Retatrutide, a unified triple agonist of the GLP-1, GIP, and glucagon receptors studied for its incretin and glucagon-arm mechanisms, weekly pharmacokinetics, and metabolic and body-composition research endpoints.